{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:08:03Z","timestamp":1788998883794,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Scientific Research Project of Department of Education of Anhui Province","award":["2023AH052011"],"award-info":[{"award-number":["2023AH052011"]}]},{"name":"Bengbu Medical University-Qilu Pharmaceutical Co.Ltd.2025 Clinical Research Collaboration Special Project","award":["BY-QLZDE016"],"award-info":[{"award-number":["BY-QLZDE016"]}]},{"name":"Bengbu Medical University Provincial College Students' Innovation & Entrepreneurship Training Program","award":["S202510367137"],"award-info":[{"award-number":["S202510367137"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16414-3","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:47:16Z","timestamp":1782391636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bidirectional relationship between the systemic immune-inflammation index and post-autologous stem cell transplantation anemia in multiple myeloma: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Lin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianfang","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachang","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"10","key":"16414_CR1","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3324\/haematol.2020.247015","volume":"105","author":"A Gulla","year":"2020","unstructured":"Gulla A, Anderson KC. Multiple myeloma: the (r)evolution of current therapy and a glance into future. Haematologica. 2020;105(10):2358\u201367.","journal-title":"Haematologica"},{"issue":"6","key":"16414_CR2","doi-asserted-by":"publisher","first-page":"e456","DOI":"10.1016\/S2352-3026(20)30099-5","volume":"7","author":"M Cavo","year":"2020","unstructured":"Cavo M, Gay F, Beksac M, Pantani L, Petrucci MT, Dimopoulos MA, et al. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02\/HO95): a multicentre, randomised, open-label, phase 3 study. Lancet Haematol. 2020;7(6):e456\u201368.","journal-title":"Lancet Haematol"},{"key":"16414_CR3","doi-asserted-by":"crossref","unstructured":"Giralt S, Garderet L, Durie B, Cook G, Gahrton G, Bruno B et al. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma. Biol Blood Marrow Transplant, 2015;21(12):2039\u20132051.","DOI":"10.1016\/j.bbmt.2015.09.016"},{"issue":"1","key":"16414_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13643-018-0785-7","volume":"7","author":"D Jeevanantham","year":"2018","unstructured":"Jeevanantham D, Rajendran V, Tremblay L, Larivi\u00e8re C, Knight A. Evidence-based guidelines for physiotherapy management of patients with multiple myeloma: study protocol. Syst Rev. 2018;7(1):118.","journal-title":"Syst Rev"},{"issue":"10272","key":"16414_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"N van de Donk","year":"2021","unstructured":"van de Donk N, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397(10272):410\u201327.","journal-title":"Lancet"},{"issue":"5","key":"16414_CR6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.medcli.2020.07.035","volume":"156","author":"LC de Allende","year":"2021","unstructured":"de Allende LC, D\u00edaz de RL, Entresotos, Conde S, D\u00edez. Anaemia of chronic diseases: Pathophysiology, diagnosis and treatment. Med Clin (Barc). 2021;156(5):235\u201342.","journal-title":"Med Clin (Barc)"},{"key":"16414_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-3-031-92033-2_13","volume":"1480","author":"L Lanser","year":"2025","unstructured":"Lanser L, Weiss G. Anemia of Inflammation. Adv Exp Med Biol. 2025;1480:179\u201395.","journal-title":"Adv Exp Med Biol"},{"key":"16414_CR8","doi-asserted-by":"crossref","unstructured":"Li Z, Luo J, Peng L, Wu B, Yu Z. Prognostic significance of systemic immune-inflammation index in hepatocellular carcinoma: a meta-analysis. Clin Transl Oncol. 2026;28(2):601\u201316.","DOI":"10.1007\/s12094-025-04028-3"},{"issue":"3","key":"16414_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.20517\/cdr.2022.23","volume":"5","author":"JJ Ignatz-Hoover","year":"2022","unstructured":"Ignatz-Hoover JJ, Driscoll JJ. Therapeutics to harness the immune microenvironment in multiple myeloma. Cancer Drug Resist. 2022;5(3):647\u201361.","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"16414_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"G Weiss","year":"2019","unstructured":"Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40\u201350.","journal-title":"Blood"},{"key":"16414_CR11","doi-asserted-by":"publisher","first-page":"655259","DOI":"10.3389\/fonc.2021.655259","volume":"11","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhang J, Luo S, Zhao X. Prognostic Significance of Systemic Immune-Inflammation Index in Patients With Diffuse Large B-Cell Lymphoma. Front Oncol. 2021;11:655259.","journal-title":"Front Oncol"},{"key":"16414_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-med-043021-032816","volume":"74","author":"E Nemeth","year":"2023","unstructured":"Nemeth E, Ganz T. Hepcidin and Iron in Health and Disease. Annu Rev Med. 2023;74:261\u201377.","journal-title":"Annu Rev Med"},{"key":"16414_CR13","doi-asserted-by":"publisher","first-page":"1391573","DOI":"10.3389\/fimmu.2024.1391573","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Xiao J, Cai W, Lu X, Liu C, Dong Y, et al. Association of the systemic immune-inflammation index with anemia: a population-based study. Front Immunol. 2024;15:1391573.","journal-title":"Front Immunol"},{"issue":"7","key":"16414_CR14","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1080\/10428194.2021.1876870","volume":"62","author":"JC Jaime-P\u00e9rez","year":"2021","unstructured":"Jaime-P\u00e9rez JC, Hern\u00e1ndez-Coronado M, Pic\u00f3n-Galindo E, Salazar-Cavazos L, Guti\u00e9rrez-Aguirre CH, G\u00f3mez-Almaguer D. Results of a completely outpatient autologous stem cell transplant program for lymphoma patients receiving reduced-intensity conditioning. Leuk Lymphoma. 2021;62(7):1619\u201328.","journal-title":"Leuk Lymphoma"},{"key":"16414_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-3-031-92033-2_14","volume":"1480","author":"D Crisell","year":"2025","unstructured":"Crisell D, Talbot N, Drakesmith H. Iron, Hepcidin, and Immunity. Adv Exp Med Biol. 2025;1480:197\u2013215.","journal-title":"Adv Exp Med Biol"},{"key":"16414_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-3-031-92033-2_12","volume":"1480","author":"X Li","year":"2025","unstructured":"Li X, Finberg KE. Iron Deficiency Anemia. Adv Exp Med Biol. 2025;1480:163\u201378.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"16414_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ijc.32303","volume":"146","author":"J Fest","year":"2020","unstructured":"Fest J, Ruiter R, Mulder M, Groot Koerkamp B, Ikram MA, Stricker BH, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer-A population-based cohort study. Int J Cancer. 2020;146(3):692\u20138.","journal-title":"Int J Cancer"},{"key":"16414_CR18","doi-asserted-by":"crossref","unstructured":"Horio T, Morishita E, Mizuno S, Uchino K, Hanamura I, Espinoza JL, et al. Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients. Cancers (Basel). 2020;12(2):424.","DOI":"10.3390\/cancers12020424"},{"key":"16414_CR19","doi-asserted-by":"crossref","unstructured":"Jalouli M. Emerging Role of Hypoxia-Inducible Factors (HIFs) in Modulating Autophagy: Perspectives on Cancer Therapy. Int J Mol Sci. 2025;26(4):1752.","DOI":"10.3390\/ijms26041752"},{"issue":"12","key":"16414_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nri.2017.103","volume":"17","author":"CT Taylor","year":"2017","unstructured":"Taylor CT, Colgan SP. Regulation of immunity and inflammation by hypoxia in immunological niches. Nat Rev Immunol. 2017;17(12):774\u201385.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"16414_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10238-024-01411-2","volume":"24","author":"V Desantis","year":"2024","unstructured":"Desantis V, Borrelli P, Panebianco T, Fusillo A, Bochicchio D, Solito A, et al. Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects. Clin Exp Med. 2024;24(1):137.","journal-title":"Clin Exp Med"},{"issue":"11","key":"16414_CR22","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/cid\/cix690","volume":"65","author":"C Girmenia","year":"2017","unstructured":"Girmenia C, Bertaina A, Piciocchi A, Perruccio K, Algarotti A, Busca A, et al. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey. Clin Infect Dis. 2017;65(11):1884\u201396.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"16414_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJMoa2312054","volume":"390","author":"P Sonneveld","year":"2024","unstructured":"Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, et al. Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. N Engl J Med. 2024;390(4):301\u201313.","journal-title":"N Engl J Med"},{"issue":"16","key":"16414_CR24","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/S1470-2045(15)00389-7","volume":"16","author":"F Gay","year":"2015","unstructured":"Gay F, Oliva S, Petrucci MT, Conticello C, Catalano L, Corradini P, et al. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial. Lancet Oncol. 2015;16(16):1617\u201329.","journal-title":"Lancet Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16414-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:17:26Z","timestamp":1788995846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16414-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16414"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16414-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki. The study protocol was reviewed and approved by the Clinical Medical Research Ethics Committee of Bengbu Medical University (Ethics Approval Number: 2024034). As this study only examined the anonymized clinical data, the ethics committee granted a waiver for obtaining individual patient informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1078"}}